228 related articles for article (PubMed ID: 28095398)
1. Aurora B expression modulates paclitaxel response in non-small cell lung cancer.
Al-Khafaji AS; Davies MP; Risk JM; Marcus MW; Koffa M; Gosney JR; Shaw RJ; Field JK; Liloglou T
Br J Cancer; 2017 Feb; 116(5):592-599. PubMed ID: 28095398
[TBL] [Abstract][Full Text] [Related]
2. AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy.
Bertran-Alamillo J; Cattan V; Schoumacher M; Codony-Servat J; Giménez-Capitán A; Cantero F; Burbridge M; Rodríguez S; Teixidó C; Roman R; Castellví J; García-Román S; Codony-Servat C; Viteri S; Cardona AF; Karachaliou N; Rosell R; Molina-Vila MA
Nat Commun; 2019 Apr; 10(1):1812. PubMed ID: 31000705
[TBL] [Abstract][Full Text] [Related]
3. High expression of Aurora-B is correlated with poor prognosis and drug resistance in non-small cell lung cancer.
Yu J; Zhou J; Xu F; Bai W; Zhang W
Int J Biol Markers; 2018 May; 33(2):215-221. PubMed ID: 29707994
[TBL] [Abstract][Full Text] [Related]
4. Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo.
Helfrich BA; Kim J; Gao D; Chan DC; Zhang Z; Tan AC; Bunn PA
Mol Cancer Ther; 2016 Oct; 15(10):2314-2322. PubMed ID: 27496133
[TBL] [Abstract][Full Text] [Related]
5. Daurinol Enhances the Efficacy of Radiotherapy in Lung Cancer via Suppression of Aurora Kinase A/B Expression.
Woo JK; Kang JH; Shin D; Park SH; Kang K; Nho CW; Seong JK; Lee SJ; Oh SH
Mol Cancer Ther; 2015 Jul; 14(7):1693-704. PubMed ID: 25882311
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of Aurora Kinase B Induces Differentially Cell Death and Polyploidy via DNA Damage Response Pathways in Neurological Malignancy: Shedding New Light on the Challenge of Resistance to AZD1152-HQPA.
Zekri A; Ghaffari SH; Yaghmaie M; Estiar MA; Alimoghaddam K; Modarressi MH; Ghavamzadeh A
Mol Neurobiol; 2016 Apr; 53(3):1808-1823. PubMed ID: 25752998
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of non-small-cell lung cancer cell lines established from patients treated with prolonged infusions of Paclitaxel.
Fujishita T; Loda M; Turner RE; Gentler M; Kashii T; Breathnach OS; Johnson BE
Oncology; 2003; 64(4):399-406. PubMed ID: 12759538
[TBL] [Abstract][Full Text] [Related]
8. Aurora Kinase B Expression, Its Regulation and Therapeutic Targeting in Human Retinoblastoma.
Borah NA; Sradhanjali S; Barik MR; Jha A; Tripathy D; Kaliki S; Rath S; Raghav SK; Patnaik S; Mittal R; Reddy MM
Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):16. PubMed ID: 33704359
[TBL] [Abstract][Full Text] [Related]
9. Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer.
Larsen SL; Yde CW; Laenkholm AV; Rasmussen BB; Duun-Henriksen AK; Bak M; Lykkesfeldt AE; Kirkegaard T
BMC Cancer; 2015 Apr; 15():239. PubMed ID: 25885472
[TBL] [Abstract][Full Text] [Related]
10. Improved response to nab-paclitaxel compared with cremophor-solubilized paclitaxel is independent of secreted protein acidic and rich in cysteine expression in non-small cell lung cancer.
Shao H; Tang H; Salavaggione OE; Yu C; Hylander B; Tan W; Repasky E; Adjei AA; Dy GK
J Thorac Oncol; 2011 Jun; 6(6):998-1005. PubMed ID: 21532503
[TBL] [Abstract][Full Text] [Related]
11. Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients.
Vischioni B; Oudejans JJ; Vos W; Rodriguez JA; Giaccone G
Mol Cancer Ther; 2006 Nov; 5(11):2905-13. PubMed ID: 17121938
[TBL] [Abstract][Full Text] [Related]
12. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).
Glorieux P; Ortmanns P; Marien S; Degives R; Degraeve D; Potvin M; Grauwels D; Schallier D
Anticancer Res; 2001; 21(2B):1487-94. PubMed ID: 11396237
[TBL] [Abstract][Full Text] [Related]
13. Aurora kinase B inhibitor barasertib (AZD1152) inhibits glucose metabolism in gastric cancer cells.
He J; Qi Z; Zhang X; Yang Y; Liu F; Zhao G; Wang Z
Anticancer Drugs; 2019 Jan; 30(1):19-26. PubMed ID: 30540594
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations.
Monzó M; Rosell R; Sánchez JJ; Lee JS; O'Brate A; González-Larriba JL; Alberola V; Lorenzo JC; Núñez L; Ro JY; Martín C
J Clin Oncol; 1999 Jun; 17(6):1786-93. PubMed ID: 10561216
[TBL] [Abstract][Full Text] [Related]
15. Taxanes, past, present, and future impact on non-small cell lung cancer.
Joshi M; Liu X; Belani CP
Anticancer Drugs; 2014 May; 25(5):571-83. PubMed ID: 24463482
[TBL] [Abstract][Full Text] [Related]
16. ATP-binding cassette B1 gene polymorphisms, mRNA expression and chemosensitivity to paclitaxel in non-small cell lung cancer cells.
Meng X; Wang G; Liu P; Hou J; Jin Y; Yu Y; Bai J; Chen F; Sun W; Fu S
Respirology; 2011 Nov; 16(8):1228-34. PubMed ID: 21883677
[TBL] [Abstract][Full Text] [Related]
17. Intracellular ATP-binding cassette transporter A3 is expressed in lung cancer cells and modulates susceptibility to cisplatin and paclitaxel.
Overbeck TR; Hupfeld T; Krause D; Waldmann-Beushausen R; Chapuy B; Güldenzoph B; Aung T; Inagaki N; Schöndube FA; Danner BC; Truemper L; Wulf GG
Oncology; 2013; 84(6):362-70. PubMed ID: 23689165
[TBL] [Abstract][Full Text] [Related]
18. Alternative efficacy-predicting markers for paclitaxel instead of CHFR in non-small-cell lung cancer.
Takeshita M; Koga T; Takayama K; Yano T; Maehara Y; Nakanishi Y; Sueishi K
Cancer Biol Ther; 2010 Nov; 10(9):933-41. PubMed ID: 20855974
[TBL] [Abstract][Full Text] [Related]
19. Combination of paclitaxel and bevacizumab in heavily pre-treated non-small-cell lung cancer (NSCLC) patients: a case series study on 15 patients.
Le Moulec S; Hadoux J; Gontier E; Chargari C; Helissey C; Lamand V; Tanz R; Farace F; Vedrine L; Bonardel G; Soria JC; Besse B
Bull Cancer; 2013 Dec; 100(12):30-7. PubMed ID: 24316967
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer.
Ceresoli GL; Gregorc V; Cordio S; Bencardino KB; Schipani S; Cozzarini C; Bordonaro R; Villa E
Lung Cancer; 2004 May; 44(2):231-9. PubMed ID: 15084388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
